Straits Times Index
3,364.69 +26.12 (+0.78%) Nikkei
40,074.69 +443.63 (+1.12%) Hang Seng
17,732.09 +13.48 (+0.08%) FTSE 100
8,166.76 +2.64 (+0.03%) Bitcoin USD
62,787.63 -546.66 (-0.86%) CMC Crypto 200
1,346.89 +2.38 (+0.18%)
SPGI Jul 2024 390.000 put
- Insider Monkey
Mixed Results Dragged S&P Global (SPGI) in Q1
Parnassus Investments, an investment management company, released the “Parnassus Value Equity Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here. In the first quarter, the Fund (Investor Shares) appreciated 10.17% outperforming the Russell 1000 Value Index’s 8.99%. Stock selection in the Information Technology and Communication Services sectors was the main […]
- PR Newswire
S&P Global Schedules Second Quarter 2024 Earnings Announcement and Conference Call for Tuesday, July 30, 2024
S&P Global's (NYSE: SPGI) second quarter 2024 results will be issued on Tuesday, July 30, 2024 via news release at approximately 7:15 a.m. Eastern Daylight Time. The news release will be available at www.spglobal.com.
- PR Newswire
Protagonist Therapeutics Set to Join S&P SmallCap 600
Protagonist Therapeutics Inc. (NASD: PTGX) will replace Encore Wire Corp. (NASD: WIRE) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, July 3. S&P Europe 350 constituent Prysmian SpA (MTAA: PRY) is acquiring Encore Wire in a deal expected to be completed soon pending final conditions.
